Compare JMSB & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JMSB | SLP |
|---|---|---|
| Founded | 2005 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 270.0M | 322.4M |
| IPO Year | N/A | 1997 |
| Metric | JMSB | SLP |
|---|---|---|
| Price | $20.34 | $18.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $22.50 | ★ $27.25 |
| AVG Volume (30 Days) | 21.3K | ★ 332.7K |
| Earning Date | 01-28-2026 | 01-08-2026 |
| Dividend Yield | ★ 1.47% | N/A |
| EPS Growth | ★ 18.50 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | $59,274,000.00 | ★ $79,179,000.00 |
| Revenue This Year | $19.50 | $2.42 |
| Revenue Next Year | $12.72 | $7.05 |
| P/E Ratio | $14.61 | ★ N/A |
| Revenue Growth | 11.69 | ★ 13.09 |
| 52 Week Low | $13.81 | $12.39 |
| 52 Week High | $21.58 | $37.67 |
| Indicator | JMSB | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 51.26 | 52.87 |
| Support Level | $20.26 | $17.74 |
| Resistance Level | $21.50 | $19.62 |
| Average True Range (ATR) | 0.45 | 0.69 |
| MACD | -0.07 | -0.11 |
| Stochastic Oscillator | 45.85 | 48.71 |
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.